648 — SoftMedx Healthcare Income Statement
0.000.00%
Consumer CyclicalsMicro Cap
Annual income statement for SoftMedx Healthcare, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 40.2 | 9.62 | 1.7 | 33.8 | 51.3 |
Cost of Revenue | |||||
Gross Profit | 23.3 | 5.22 | 0.79 | 13.7 | 21.1 |
Selling / General / Administrative Expenses | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 102 | 44 | 10.1 | 34.8 | 24 |
Operating Profit | -62.1 | -34.4 | -8.45 | -1.08 | 27.3 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -79.2 | -52.5 | -24.7 | -16.6 | 14.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -79.1 | -52.5 | -24.7 | -19.2 | 12.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -77 | -50.8 | -26.3 | -19.2 | 12.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -77 | -50.8 | -26.3 | -19.2 | 12.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.216 | -0.144 | -0.105 | -0.059 | 0.051 |